Literature DB >> 20938733

The prevalence of human papillomavirus infection in Mombasa, Kenya.

Hugo De Vuyst1, Maria Rita Parisi, Andrew Karani, Kishor Mandaliya, Lucy Muchiri, Salvatore Vaccarella, Marleen Temmerman, Silvia Franceschi, Flavia Lillo.   

Abstract

OBJECTIVES: A human papillomavirus (HPV) prevalence survey was done in Mombasa, Kenya, to improve the knowledge of HPV prevalence and genotype distribution in sub-Saharan African countries overall, and in women of different ages.
METHODS: HPV prevalence was assessed using PCR in women older than 15 years attending family planning and mother-child care services.
RESULTS: Among 496 women, HPV prevalence was high (42.3%; 95% CI: 37.9-46.8; world age-standardized). Moreover, 46% of HPV-positive women harbored multiple-type infections. The most common types were HPV58 (10.5% of women), HPV16 (7.7%), HPV53 (6.7%), HPV18 (4.6%), and HPV6 (4.4%), and the prevalence of any high-risk HPV type was 28.8%. HPV prevalence was elevated among all age-groups (range 36.4-45.7%). Independent associations with HPV positivity were found for being in a polygamous marriage (OR = 1.7) and lifetime number of sexual partners (OR for ≥ 3 vs. 1 = 1.5), although they were of only borderline statistical significance.
CONCLUSIONS: These findings differ from other world regions, showing a high HPV burden in all age-groups with a high proportion of multiple-type infections. Our data strengthen the urgency of HPV vaccination in Kenya but also highlight the elevated number of women who would have positive results in an HPV-based screening program in the country.

Entities:  

Mesh:

Year:  2010        PMID: 20938733     DOI: 10.1007/s10552-010-9645-z

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  13 in total

Review 1.  The burden of human papillomavirus infections and related diseases in sub-saharan Africa.

Authors:  Hugo De Vuyst; Laia Alemany; Charles Lacey; Carla J Chibwesha; Vikrant Sahasrabuddhe; Cecily Banura; Lynette Denny; Groesbeck P Parham
Journal:  Vaccine       Date:  2013-12-29       Impact factor: 3.641

Review 2.  The role of infections in the causation of cancer in Kenya.

Authors:  Vivian C Tuei; Geoffrey K Maiyoh; Fidelis T Ndombera
Journal:  Cancer Causes Control       Date:  2022-09-10       Impact factor: 2.532

3.  Prevalence and risk factors for cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of the Congo: a cross-sectional study.

Authors:  Catherine Ali-Risasi; Kristien Verdonck; Elizaveta Padalko; Davy Vanden Broeck; Marleen Praet
Journal:  Infect Agent Cancer       Date:  2015-07-15       Impact factor: 2.965

Review 4.  Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.

Authors:  Rebecca Kemunto Ogembo; Philimon Nyakauru Gona; Alaina J Seymour; Henry Soo-Min Park; Paul A Bain; Louise Maranda; Javier Gordon Ogembo
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

5.  Human Papillomavirus types distribution among women with cervical preneoplastic, lesions and cancer in Luanda, Angola.

Authors:  Paciência de Almeida Damião; Michelle Oliveira-Silva; Miguel Ângelo Moreira; Natalia Poliakova; Maria Emilia Rt de Lima; José Chiovo; Alcina Frederica Nicol
Journal:  Pan Afr Med J       Date:  2016-07-22

6.  Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.

Authors:  Zacharie Ndizeye; Davy Vanden Broeck; Ramokone Lisbeth Lebelo; Johannes Bogers; Ina Benoy; Jean-Pierre Van Geertruyden
Journal:  PLoS One       Date:  2019-06-25       Impact factor: 3.240

Review 7.  Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives.

Authors:  Chee Kai Chan; Gulzhanat Aimagambetova; Talshyn Ukybassova; Kuralay Kongrtay; Azliyati Azizan
Journal:  J Oncol       Date:  2019-10-10       Impact factor: 4.375

8.  Mapping the Current and Future Noncommunicable Disease Burden in Kenya by Human Immunodeficiency Virus Status: A Modeling Study.

Authors:  Mikaela Smit; Pablo N Perez-Guzman; Kennedy K Mutai; Rachel Cassidy; Joseph Kibachio; Nduku Kilonzo; Timothy B Hallett
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 9.079

9.  Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya.

Authors:  H De Vuyst; N R Mugo; M H Chung; K P McKenzie; E Nyongesa-Malava; V Tenet; J W Njoroge; S R Sakr; Cjl M Meijer; P J F Snijders; F S Rana; S Franceschi
Journal:  Br J Cancer       Date:  2012-10-02       Impact factor: 7.640

10.  Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities.

Authors:  Samira Zoa Assoumou; Angelique Ndjoyi Mbiguino; Barthelemy Mabika Mabika; Sidonie Nguizi Ogoula; Mohammed El Mzibri; Abdelkrim Khattabi; My Mustapha Ennaji
Journal:  Infect Agent Cancer       Date:  2016-01-15       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.